PMD23- IS MARKOV CHAIN/DECISION TREE APPROACH BETTER THAN COST FUNCTION APPROACH IN MODELING THE PHARMACEUTICAL COSTS FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER? AN EMPIRICAL STUDY BASED ON A LARGE CLAIM DATABASE
May 1, 2003, 00:00
10.1016/S1098-3015(10)64101-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64101-0/fulltext
Title :
PMD23- IS MARKOV CHAIN/DECISION TREE APPROACH BETTER THAN COST FUNCTION APPROACH IN MODELING THE PHARMACEUTICAL COSTS FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER? AN EMPIRICAL STUDY BASED ON A LARGE CLAIM DATABASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64101-0&doi=10.1016/S1098-3015(10)64101-0
First page :
Section Title :
Open access? :
No
Section Order :
303